SINGLE USE PRODUCTS IN BIOPHARMACEUTICALS MARKET ANALYSIS

Single-use products are products such as bioreactors bags that are used once and then discarded in the biopharmaceutical manufacturing process. These single-use products cannot be reused for processing purposes. Plastic, polyethylene, and paper for the filtration unit are the materials used to manufacture these single-use goods. By employing single-use goods, it can save money on high-cost equipment, lower the danger of contamination in cell culture, and cut down on set-up, testing, validation, and documentation time. Moreover, as the global biopharmaceutical market is flourishing for drug development, vaccine production, and other medicinal breakthroughs, thus the market for single-use products used in biopharmaceutical processing is expected to witness growth. For instance, according to India Brand Equity Foundation (IBEF), Indian drugs and pharmaceuticals export has reached US$ 5.78 billion from April 2021 to June 2021.

Global Single Use Products in Biopharmaceuticals Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 11, 2021, Single Use Support, a provider and manufacturer of storing, freezing, filing, thawing, and shipping solutions for drug substances, published an article described the shortage on single use assemblies in pharmaceutical market as the research and developments activities increase for vaccine production for COVID 19, where early stage clinical products rely on small volume production for trials and bulk drug requirement can be scaled up to correct volume.

The increasing inorganic activities such as agreements, expansion, and partnerships in different regions by market players for manufacturing single use products in biopharmaceutical is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 6, 2020, Cytiva, a technological products and services in field of bioprocessing, manufacturing, research and developments, and provider of therapeutics signed agreements with Wego, Clover is cloud-based Android point of sale platform, Jinbo, and Zhifei a company of high-tech biological enterprise integrating the R&D, production, marketing for investments in the production of therapeutics and to scale up the protein based COVID-19 S-Trimmer subunit vaccine in China.

The global single use products in biopharmaceuticals market is estimated to be valued at US$ 1,821.2 Mn in 2021 and is expected to exhibit a CAGR of 16.7% over the forecast period (2021-2028).  

Figure 1: Global Single Use Products in Biopharmaceuticals Market Share, (%), Analysis, By Product Type, 2021

To learn more about this report, request sample copy

Increasing investment in single use products by the market players used for biopharmaceutical industry is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.

The increasing investments in single use products for pharmaceutical processing is expected to fuel growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, In December 2019, Lonza, a global partner of biotech, pharmaceutical markets has announced investment of US$ 92 million for building new large scale facility with 20,000L bioreactors to fulfill the market demand of biologics, where single use technology facility will support the clinical manufacturing processes.

Market players are engaged in launching products and applying for approval from regulatory authorities indicated for use in biopharmaceutical processing. This is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.

Increasing approvals from the regulatory authorities and launches of products are expected to drive growth of the market over the forecast period. For instance, on February 9, 2021, 3M health care, a drug development company’ designed single use AEX solution for biologic drug manufacturing. This manufacturing workflow will help in reducing the number of processing steps of manufacturing product for improving processing.

 Global Single Use Products in Biopharmaceuticals Market – Regional Analysis

On the basis of region, global single use products in biopharmaceuticals market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position during the forecast period, owing to the expansion of production unit by market players. For instance, on September 27, 2021, Sartorius AG, a pharmaceutical and laboratory equipment supplier, announced expansion business operations of bioprocessing unit in North America region. This expand will benefit the region because drug availability will grow as transportation costs decrease.

Furthermore, Europe is also estimated to witness a significant growth in the single use products in biopharmaceuticals market, owing to increasing investments by the market players and research institute. For instance, on March 17, 2021, Merck KGaA, which is a company of  leading science and technology announced the expansion of single use assembly production unit in France to manufacture COVID-19 vaccines and therapies and the company has invested US$ 28 million for development of the unit.

Figure 2: Global Single Use Products in Biopharmaceuticals Market (US$ Mn), by Region, 2021

To learn more about this report, request sample copy

Global Single Use Products in Biopharmaceuticals Market – Competitive Landscape

Major players operating in the global single use products in biopharmaceuticals market include Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor, Meissner, New Horizon Biotech, PBS-Biotech,  Xcellerex,  and Single Use Support GmbH.